Exoskeleton Variability Optimization
Key facts
- Who runs it
- University of Nebraska
- Where
- Omaha, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 9 people enrolled
- Started
- 31 Jan 2022
- Ended
- 28 Mar 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Exoskeleton Optimization
- Endurance Evaluation
- Record updated
- 19 June 2025
- Why it stopped
- The second arm was not completed since the first arm was not successful based on the convergence criteria.
Who can take part
- Age
- 19 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Ability to provide written consent
- Chronic claudication history
- Ankle-brachial index < 0.90 at rest
- Stable blood pressure, lipids, and diabetes for > 6 weeks
- Ability to walk on a treadmill for multiple five-minute spans
- Ability to fit in exoskeleton; Waist circumference 78 to 92 centimeters (31 to 36 inches); Thigh circumference 48 to 60 centimeters (19 to 24 inches); Minimal thigh length 28 centimeters (11 inches)
Who cannot take part
- Resting pain or tissue loss due to peripheral artery disease (PAD, Fontaine stage III and IV)
- Acute lower extremity event secondary to thromboembolic disease or acute trauma
- Walking capacity limited by diseases unrelated to PAD, such as:; Neurological disorders; Musculoskeletal disorders (arthritis, scoliosis, stroke, spinal injury, etc.); History of ankle instability; Knee injury; Diagnosed joint laxity; Lower limb injury; Surgery within the past 12 months; Joint replacement; Pulmonary disease or breathing disorders; Cardiovascular disease; Vestibular disorder
- Current illness
- Foot ulceration
- Acute injury or pain in lower extremity
- Inability to follow visual cues due to blindness
- Inability to follow auditory cues due to deafness
- Pregnant
Where in United States
- University of Nebraska OmahaOmaha, United States
About the trial
What the trial wants to find out
Exoskeletons, wearable devices that assist with walking, can improve mobility in clinical populations. With exoskeletons, it is crucial to optimize the assistance profile. Recent studies describe algorithms (i.e., human-in-the-loop) to optimize the assistance profile with real-time metabolic measurements. The needed duration of current human-in-the-loop (HITL) algorithms range from 20 minutes to 1 hour which is longer than the average duration that most patients with peripheral artery disease (PAD) can walk. Because of this limited walking duration, it is often not possible for patients with PAD to reach steady-state metabolic cost, which makes these measurements are not useful for optimizing exoskeletons. In this study, investigators intend to develop and evaluate HITL optimization methods for exoskeletons and use the information to design and evaluate a portable hip exoskeleton. Shorter and more clinically feasible HITL optimization strategies based on experiments in healthy adults might allow utilizing these optimization strategies to become available for patient populations such as patients with PAD.
The 2 groups in the trial
- Optimal Assistance PatternTreatment being tested
An optimization algorithm will change the assistance pattern on the hip exoskeleton during walking sessions and the optimal assistance pattern will be determined when gait variability is minimized.
Treatment: Exoskeleton Optimization
- Endurance EffectdsTreatment being tested
Endurance of participants using ground reaction force (Bertec treadmill), walking speed (Bertec treadmill), indirect calorimetry (Cosmed), and motion capture (Vicon) will be determined.
Treatment: Endurance Evaluation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Exoskeleton Variability Optimization for Reducing Gait Variability for Patients With Peripheral Artery Disease
- Record updated
- 19 June 2025